MannKind Corporation

Links: Y! PP Pick KLLJ Investments on SA Afrezza Blogspot TR MNKD Dreamboat Mann Interview MNKDchrt Mannkind homepage 171 trial results 175 trial results George Rho's Informed Commentary Trial FAQ's

MNKD / Message Board

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
15136	Been slowly accumulating shares at these low prices...	GN	put_lipstick_on_this_pig		0	6/26/2017 12:58:36 PM

15135	Getting interesting again: will there be another increase this coming week?	GN	splaylaywahtheepi		0	6/25/2017 8:27:23 PM

15134	Re: Russell rebalancing explains price action today and MNKD was removed	GN	techstockguru_2000		0	6/25/2017 12:54:58 PM

15133	Re: Russell rebalancing explains price action today and MNKD was removed	GN	tocentsworth		0	6/24/2017 4:01:15 PM

15132	Re: Script Ct for week ending June 16, 2017 - TRx 385 Up 24.7% Refills 159 Up 1% - Note this different data source	GN	tocentsworth		0	6/24/2017 3:54:37 PM

15131	Re: Script Ct for week ending June 16, 2017 - TRx 385 Up 24.7% Refills 159 Up 1% - Note this different data source	GN	splaylaywahtheepi		0	6/23/2017 10:15:50 PM

15130	Russell rebalancing explains price action today and MNKD was removed	GN	techstockguru_2000		0	6/23/2017 4:45:19 PM

15129	Re: Script Ct for week ending June 16, 2017 - TRx 385 Up 24.7% Refills 159 Up 1% - Note this different data source	GN	techstockguru_2000		1	6/23/2017 2:04:27 PM

15128	Script Ct for week ending June 16, 2017 - TRx 385 Up 24.7% Refills 159 Up 1% - Note this different data source	GN	astrojny		5	6/23/2017 1:07:57 PM

15127	PPS moving up nicely today. Good script numbers coming???...EOM	GN	put_lipstick_on_this_pig		0	6/23/2017 10:22:19 AM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2016 Investorvillage.com. All rights reserved. User Agreement